Table 1.
The global prevalence of AMR among ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pathogens.
| Pathogens | Enterococcus faecium | Staphylococcus aureus | Klebsiella pneumoniae | Acinetobacter baumannii | Pseudomonas aeruginosa | Enterobacter spp. | References | |
|---|---|---|---|---|---|---|---|---|
| Country | ||||||||
| Thailand | - | - | ER | ER | - | - | [4] | |
| South India | - | - | - | - | S | - | [5] | |
| India | ER | ER | ER | ER | ER | ER | [6] | |
| India (Veterinary Cases) | ER | ER | ER | ER | ER | ER | [7] | |
| Iran | ER | HR | R | ER | ER | HR | [14] | |
| Asia-Pacific | - | - | R | ER | S | S | [8] | |
| Southern Italy | S | R | S | ER | R | - | [9] | |
| Romania | HR | R | HR | HR | HR | - | [10] | |
| Romania | H | ER | ER | ER | S | - | [11] | |
| South Africa | R | S | ER | H | S | - | [12] | |
| Brazil | ER | ER | HR | HR | ER | ER | [13] | |
| Latin-America | - | - | R | ER | S | S | [8] | |
- (N/A) = data on the AMR prevalence are not available in the study, S (Susceptible) = 50% of the organism does not show resistance against any antibacterial agent; R (Resistant) = 50% of the organism must show resistance against an antibacterial agent from 1 of the antibiotic groups; HR (Highly Resistant) = 50% of the organism must show resistance against antibacterial agents from at least 2 of the antibiotic groups; ER (Extremely Resistant) = 50% of the organism must show resistance against antibacterial agents from at least 3 of the antibiotic groups. Antibiotic groups: Aminoglycosides, Carnapenems, Cephalosporins, Glycopeptides, Lincosamides, Lipopeptide, Macrolides, Monobactams, Nitrofurans, Penicillin, Fluoroquinolones, Sulfonamides, Tetracycline.